Professional
Added to YB: 2025-09-22
Pitch date: 2025-06-30
4568.T [bullish]
Daiichi Sankyo Company, Limited
+1.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
Market Cap
JPY 6.5T
Pitch Price
JPY 3.3K
Price Target
N/A
Dividend
2.21%
EV/EBITDA
15.13
P/E
22.47
EV/Sales
3.20
Sector
Pharmaceuticals
Category
growth
Show full summary:
Platinum Japan Fund New Position: Daiichi Sankyo Company, Limited
4568.T (new position): Strong oncology position with unique ADC technology, notably Enhurtu cancer treatment potentially becoming standard of care across multiple cancer types driving profit growth. However, US pharma pricing uncertainty & recent Datroway development disappointment create headwinds.
Read full article (1 min)